Business Wire

2020 Yiwu Imported Commodities Fair is Being Held in World Capital of Small Commodities

13.11.2020 16:38:00 EET | Business Wire | Press release

Share

The 2020 China Yiwu Imported Commodities Fair opened in Yiwu City on November 13, 2020 and will continue until the 16th. As a professional, international and market-oriented event, Yiwu Imported Commodities Fair is committed to becoming China's top brand for imported consumer goods.

View the 2020 Yiwu Imported Commodities Fair album:

https://as.alltuu.com/v4/albumset/1001142273/

The Fair has five pavilions, namely Quality Life (Wine & Coffee), Asia Pavilion, Europe Pavilion, America-Oceania-Africa Pavilion, and Quality Life (Home Decoration Materials), to exhibit products from 78 countries and regions.

The Fair attracted nearly 1,000 exhibitors, one third of which were newcomers. Among them were the second largest butter cookie manufacturer from Denmark, the well-known organic superfood manufacturer from Germany, and many well-known Australian companies. Meanwhile, as this year’s Fair was opened right after the closure of China International Import Expo (CIIE) in Shanghai, 93 CIIE exhibitors also came to the Fair, a significant increase from last year’s 26.

Government participants included the Consulate General of the Republic of Korea in Shanghai, the Consulate General of the Socialist Republic of Vietnam in Shanghai, the Consulate General of the Eastern Republic of Uruguay in Shanghai, the China-Britain Business Council, The Canada International Trade Promotion Society, and the West Australia Trade and Investment Promotion Council.

As the country of honor, Russia brought more than 30 companies including the Russian Agricultural Group. Representatives from the Russian Consulate in Shanghai, the Russian Cultural Center in Beijing, and the Russian Export Center Group attended the Fair to showcase various aspects of the country, including economy, trade, culture and arts.

Varied supporting activities were prepared for exhibitors, buyers and visitors. In addition to a number of business themed forums and business matchmaking meetings, multiple cultural activities were held. For instance, Russia brought ethnic performances and food appreciation; the British Pavilion invited visitors on site to experience the purest British fashion; the Latte Art competition in the coffee products area attracted a lot of attention.

Another highlight of the Fair was the debut of the mascot “Jin Jin”, a lively and lovely white gosling, whose vibrant cartoon image reflects the enthusiasm and diversity of the Fair, greatly enhancing the image awareness of the Fair.

For more:

Official website: http://www.importfair.cn/en

Facebook: https://www.facebook.com/yiwuimportfair/

Instagram: https://www.instagram.com/yiwu_importedfair/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Chim Chen
service@yiwufair.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated with TRD, alongside cognitive and emotional patterns, including getting stuck in negative or repetitive ways of thinking, difficulty shifting perspective or navigating emotions, and feeling disconnected from pleasure or motivation1-8. While TRD originates as MDD, its burden and resistance to standard treatments distinguish it as a more complex condition. Compared to MDD, TRD patients experience almost 3x long

NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 13:00:00 EEST | Press release

NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these signals to inform where they plan and prioritize media investment. “Marketers shouldn’t have to guess where demand is coming from before they invest,

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases15.9.2026 13:00:00 EEST | Press release

QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS). Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs. “This collaboration with Lilly represents a validation of our PLNP technology platform and its potential to address some of the most challenging delivery problems

Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership15.9.2026 12:16:00 EEST | Press release

Axo Longevity today announced the close of an oversubscribed $5M seed round to expand its preventive health membership across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910642125/en/ Axo Longevity preventive health membership The round was backed by MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment, alongside angel investors including Dr. Jorge Planas of Clinica Planas Barcelona and Daniel Kulle, former President of H&M and former CEO of Forever 21. Developed to help people understand what is happening inside their body before symptoms appear, Axo Longevity moved from build to live operations in just twelve weeks. The platform is expanding globally, now operating in the United Kingdom, Ireland, Spain, Germany, and the Netherlands, as well as in its first Latin American market, Peru. It is supported by more than 1,400 laboratory

Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth15.9.2026 12:00:00 EEST | Press release

Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven healthcare companies and worked closely with leadership teams on long-term value creation, partnerships, financing and organizational development. Following a thorough selection process led by the Board of Directors, David will succeed Interim Group CEO Jean-Marc Bellemin, who has successfully led the Group since 15 May 2026, while also continuing in his permanent role as Group CFO. Maria Paola Chiesi, Chiesi Group Chair, commented: “We are delighted to welcome David to Chiesi at a time of strong momentum for the company. Innovati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye